Rapid non-destructive quantitative analysis of clarithromycin in capsule by near-infrared diffuse reflectance spectrometry

Journal of China Pharmaceutical University

Volumn 34, Issue 5, 2003, Pages 473-474

  Sun, Mei Ling ^a   Xiang, Bing Ren ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Clarithromycin capsule; Near infrared diffuse reflectance spectrometry; Partial least square method

Indexed keywords

CLARITHROMYCIN;

ARTICLE; DRUG CAPSULE; INFRARED SPECTROMETRY; MATHEMATICAL MODEL; QUANTITATIVE ANALYSIS; REFLECTOMETRY;

EID: 28444460307     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Barry AL, Jones RN, Thorn berry C. In vitro activities of arithromycin (cp62, 993), clarithromycin (A-56268; TE-031), erythromycin, erythromycin, roxithromycin, and clindamycin [J]. Anti microb Agents Chemother, 1988,32(5):752.
2. Piscitelli SC, Danziger LN, Rodvold KA. Clarithromycin and azithromycin: new macrolide antibiotics[J]. Clin Pharm, 1992,11:137.
3. Chen WL, Ren YJ. J Pharm Pract, 2000,18(6):381-382.
4. Jiang XM, Xie YZ. Acad J Guangdong Coll Pharm, 1999,15(3):174-175.
5. Morgan DK, Brown DM, Rotsch TD, et al. A reversed-phase high-performance liquid chromatographic method for the determination and identification of clarithromycin as the drug substance and in various dosage forms[J]. J Pharm Biomed Anal, 1991,9(3):261.
6. Erah PO, et al. Ion-pair high performance liquid chromatographic assay method for the assessment of clarithromycin stability in aqueous solution and in gastric juice[J]. J Chromatogram B, 1996,682:73.
7. Sun ML, Xiang BR. China Pharm Univ, 2003,34(3):240-243.